钆塞酸增强MRI上亚厘米肝细胞癌的改进诊断算法
本研究评估了LI-RADS对亚厘米肝细胞癌(HCC)的诊断准确性,并探讨了新的诊断标准(门静脉期或移行期廓清)是否提高诊断性能。在225例患者的240个亚厘米病灶中,新标准(非环状动脉期高强化且门静脉期或移行期非周边廓清)较LR-4类别提高了敏感性(68.2% vs 56.8%),特异性相当(91.7% vs 92.6%)。
要点
- 对于亚厘米HCC,非环状动脉期高强化、门静脉期或移行期非周边廓清、肝胆期低信号是独立预测因子。
- 新标准(非环状动脉期高强化且门静脉期或移行期非周边廓清)较LR-4提高敏感性(68.2% vs 56.8%)。
- 新标准特异性与LR-4相当(91.7% vs 92.6%),可用于提高亚厘米HCC的检出。
关键影像表现/征象
- 非环状动脉期高强化、门静脉期或移行期廓清、肝胆期低信号是多变量分析中亚厘米HCC的显著预测因子。
- 新标准(非环状动脉期高强化且门静脉期或移行期非周边廓清)的敏感性为68.2%,特异性为91.7%。
- LR-4类别的敏感性为56.8%,特异性为92.6%。
诊断标准与关键数值
- LR-4类别诊断亚厘米HCC的敏感性56.8%、特异性92.6%。
- 新标准(非环状动脉期高强化且门静脉期或移行期非周边廓清)敏感性68.2%、特异性91.7%,较LR-4敏感性提高(p=0.011),特异性相当(p>0.999)。
- 与非环状动脉期高强化且门静脉期廓清相比,新标准敏感性提高(68.2% vs 49.2%,p<0.001),特异性略降低(91.7% vs 94.4%,p=0.250)。
临床应用与阅片要点
- 在钆塞酸增强MRI上,对于亚厘米病灶,应关注非环状动脉期高强化、门静脉期或移行期非周边廓清及肝胆期低信号。
- 新标准可提高亚厘米HCC的诊断敏感性,但需注意特异性与LR-4相当,避免过度诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Accurate diagnosis of subcentimeter hepatocellular carcinoma (HCC) is a challenge also with gadoxetic acid-enhanced MRI (EOB-MRI). This study aimed to assess the diagnostic accuracy of the Liver Imaging Reporting and Data System (LI-RADS) for subcentimeter HCC and to determine whether new diagnostic criteria (washout either on portal venous phase (PVP) or transitional phase (TP)) would improve the diagnostic performance.
METHODS: We evaluated 240 subcentimeter observations in 225 consecutive treatment-naïve patients at risk of HCC. Final diagnoses were 132 HCCs (all by pathology) and 108 non-HCC (41 by pathology and 67 by follow-up). Two radiologists assessed MR imaging features and assigned LI-RADS categories. A variety of diagnostic criteria were developed by combining significant MRI features based on washout on PVP or TP. Diagnostic performance was compared.
RESULTS: Non-rim arterial phase hyperenhancement (non-rim APHE), washout on PVP or TP, and hepatobiliary-phase hypointensity were significant predictors for subcentimeter HCC diagnosis according to multivariable analysis. One criterion (non-rim APHE and washout on PVP or TP) yielded higher sensitivity (68.2% vs. 56.8%, p = 0.011) with comparable specificity (91.7% vs. 92.6%, p > 0.999) compared to the LR-4 category. This criterion had improved sensitivity (68.2% vs. 49.2%, p < 0.001) and slightly decreased specificity (91.7% vs. 94.4%, p = 0.250) compared to non-rim APHE with washout on PVP.
CONCLUSIONS: LI-RADS exhibits modest diagnostic performance for subcentimeter HCC. Our new criterion (non-rim APHE and non-peripheral washout on PVP or TP) may increase the diagnostic sensitivity without compromised specificity compared to the LR-4 category.
KEY POINTS: • The LR-4 category shows modest diagnostic performance for the diagnosis of subcentimeter HCC on EOB-MRI with a sensitivity and specificity of 56.8% and 92.6%, respectively. • Non-rim APHE, non-peripheral washout on PVP or TP, and HBP hypointensity were independent predictors for the diagnosis of subcentimeter HCC. • The combination of non-rim APHE and non-peripheral washout on PVP or TP improves the sensitivity from 56.8 to 68.2% (p = 0.011) with comparable specificity (91.7 vs. 92.6%, p > 0.999).
引用
- Huang, Zhou, Wu, et al. An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid-enhanced MRI. Eur Radiol. 2022. PMID: 36472696. doi:10.1007/s00330-022-09282-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。